Effect of Hippotherapy and Schroth Exercise on Pulmonary Function and Aerobic Capacity in Idiopathic Scoliosis

Sponsor
Batterjee Medical College (Other)
Overall Status
Completed
CT.gov ID
NCT04833868
Collaborator
Taif University (Other)
45
1
2
12.5
3.6

Study Details

Study Description

Brief Summary

BACKGROUND: Idiopathic scoliosis has been identified as a common spinal malalignment that negatively impacts the respiratory system and physical conditioning in adolescents. Hippotherapy is an equestrian intervention that optimizes physical performance and mobility in a bunch of contexts; however, its influence on pulmonary function remains unclear.

AIM: This research aimed to analyze the impact of ten weeks of hippotherapy combined with Schroth exercises on ventilatory function and aerobic capacity in AIS.

DESIGN: Randomized Controlled Trial SETTING: Outpatients attend a single center that includes a rehabilitation room and recreational riding center.

POPULATION: Forty-five patients were arbitrarily recruited to the experimental (N= 22) and control group (N=23).

METHODS: Patients in the experimental group received 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks. The two groups attended a 60-minute session of Schroth's intervention, 3 times/ week for 10 weeks. Two-way ANOVA for between-group comparisons and independent t-test for within-group comparisons were used in the statistical analysis.

Condition or Disease Intervention/Treatment Phase
  • Other: hippotherapy and schroth exercise
  • Other: schroth exercise
N/A

Detailed Description

A total of 45 patients (13 males and 32 females) participated in the current study. The participants were assigned to one of two groups in a random manner: an experimental group who received hippotherapy combined with Schroth Exercise and the control group who received only schorth exercise. (FVC, FEV1, FEV1/FVC, MVV, and 6MWT) were measured before and after 10 weeks intervention

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A Randomized Controlled TrialA Randomized Controlled Trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy of Hippotherapy Combined With Schroth Exercises on Pulmonary Function and Aerobic Capacity in Adolescents With Idiopathic Scoliosis: A Randomized Controlled Trial
Actual Study Start Date :
Feb 20, 2020
Actual Primary Completion Date :
Dec 18, 2020
Actual Study Completion Date :
Mar 7, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: hippotherapy combined with Schroth Exercise

received hippotherapy combined with Schroth Exercise hippotherapy session for 30 minutes of walking and sitting trot training, 15 sessions split into 2 phases over ten weeks in addition to 60-minute session Schroth's intervention, 3 times/ week for 10 weeks

Other: hippotherapy and schroth exercise
pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week hippotherapy intervention combined with Schroth exercise

Active Comparator: Schroth Exercise

received Schroth's intervention for a 60-minute session, 3 times/ week for 10 weeks

Other: schroth exercise
pulmonary function and aerobic capacity were measured in patients with mild idiopathic scoliosis before and after 10-week of Schroth exercise

Outcome Measures

Primary Outcome Measures

  1. FVC in liters [ten weeks]

    change in FVC measured Using Spiromaster PC-10 Spirometer

  2. FEV1 in liters [ten weeks]

    change in FEV1 measured Using Spiromaster PC-10 Spirometer

  3. MVV in liters/min [ten weeks]

    change in MVV measured Using Spiromaster PC-10 Spirometer

  4. FEV1/FVC in percentage [ten weeks]

    change in FEV1/FVC measured Using Spiromaster PC-10 Spirometer

  5. aerobic capacity [ten weeks]

    6MWT

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all types of curves,

  • curves between 10 and 20 degrees (29),

  • Risser grade 0 to 5

  • the availability to be engaged in once a week visit

Exclusion Criteria:
Adolescents with:
  • obstructive pulmonary diseases

  • associated neuromuscular diseases

  • recent infectious episodes in the previous two months

  • history of cardiovascular or psychological disorders

  • any significant history of riding horses

Contacts and Locations

Locations

Site City State Country Postal Code
1 Battarjee Medical College Jeddah Saudi Arabia

Sponsors and Collaborators

  • Batterjee Medical College
  • Taif University

Investigators

  • Principal Investigator: Mohamed M. Abdel Ghafar, Ph.D, Batterjee Medical College

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed A. Abdel Ghafar, associate Professor, Batterjee Medical College
ClinicalTrials.gov Identifier:
NCT04833868
Other Study ID Numbers:
  • BMC
First Posted:
Apr 6, 2021
Last Update Posted:
Apr 13, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed A. Abdel Ghafar, associate Professor, Batterjee Medical College
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 13, 2021